Summary
Multiple diagnostic tests and risk factors are commonly available for many diseases. This information can be either redundant or complimentary. Combinations of these tests and risk factors may improve the diagnostic/predictive accuracy but also may unnecessarily increase complexity, risks, and/or costs. The improved accuracy gained by including additional variables can be evaluated by the increment of the area under (AUC) the receiver operating characteristic (ROC) curves with and without the new variable(s). In this paper, we derive a new test statistic to accurately and efficiently determine the statistical significance of this incremental AUC under a multivariate normality assumption. Our test links the difference in AUC to a quadratic form of a standardized mean shift in a unit of the inverse covariance matrix through a properly linear transformation of all diagnostic variables. The distribution of the estimator of the quadratic form is related to the multivariate Behrens-Fisher problem. We provide explicit mathematical solutions of the estimator and its approximate noncentral F-distribution, type I error rate, and sample size formula. We use simulation studies to prove that our new test maintains prespecified type I error rates as well as reasonable statistical power under practical sample sizes. We use data from the Study of Osteoporotic Fractures (SOF) as an application example to illustrate our method.
Keywords: Area under ROC curves, Behrens-Fisher problem, Noncentral F distribution, Receiver operating characteristic curve
1 Introduction
The utility of a diagnostic test is measured in sensitivity and specificity. For ordinal diagnostic variables, a receiver operating characteristic (ROC) curve plots the false positive rate (FPR, or 1-specificity) and the true positive rate (TPR, or sensitivity) over the diagnostic decision range. The area under the ROC curve (AUC), ranging from 0.5 to 1, is a summary measure of overall diagnostic utility (Pepe et al., 2004; Wang et al., 2006; Ware, 2006). For many diseases, more than one diagnostic test is available, and combining them may improve the diagnostic accuracy. While the optimal method to summarize multiple variables is the likelihood ratio score (McIntosh and Pepe, 2002; Neyman and Pearson, 1933), the most common medical applications use simple linear combinations. Jin and Lu proposed a bootstrap-based non-parametric test (Jin and Lu, 2008) and a permutation test (Jin and Lu, 2009a) to confirm the non-inferiority of linear combinations to the optimal likelihood ratio score. In the remaining paper, we will focus only on linear combinations of diagnostic variables. The ROC curve corresponding to linear combinations has been called the generalized ROC (GROC) curve by Reiser and Faraggi (Reiser and Faraggi, 1997).
Under an assumption of multivariate normally distributed diagnostic variables for both diseased and non-diseased populations, Su and Liu (Su and Liu, 1993) proved that the Fisher’s discriminant function is the optimal linear combination (OLC) that maximizes the AUC of the ROC curves. Jin and Lu (Jin and Lu, 2009b) extend Su and Liu to the generalized linear models. Pepe and colleagues (Pepe, Cai and Longton, 2006; Pepe and Thompson, 2000) relaxed the multivariate normality assumption and found linear forms which maximize the non-parametric estimate of the AUC. Schisterman, Schisterman, Faraggi and Reiser (Schisterman, Faraggi and Reiser, 2004) discussed linear combinations of multivariate normally distributed diagnostic variables with an adjustment for covariates. Liu, Schisterman and Zhu (Liu, Schisterman and Zhu, 2005) proposed the OLC of multivariate normal variables for a given range of specificity. Cai and Cheng (Cai and Cheng, 2008) proposed robust combination of multiple diagnostic tests for censored data. While these papers constructed the OLCs, they did not evaluate the incremental AUC by adding new variables to a panel of possibly prior multiple diagnostic variables.
The OLCs with and without new variables are different. Adding new variables to a panel of multiple diagnostic variables always increases the AUC of the ROC curve. However, the increment in the apparent AUC may be too small to justify the increase in cost, risk, or logistic complications. This paper addresses statistical estimation and inference for the incremental AUC. We focus our comparisons on linear combinations of multivariate normal diagnostic variables based on linear discriminant function. Our test compares two AUCs from two combinations based on an incremental standardized quadratic form. Explicit analytic estimator and test statistics are derived. For continuous diagnostic variables that fail the normal distributional assumption, a Box-Cox type power transformation can be used prior to analysis.
Our paper is organized as follows. In Section 2, we describe the ROC model for linear combinations and define the index of incremental utility. In Section 3, we discuss the estimator and its approximate distribution. In Section 4, we propose a hypothesis testing procedure and sample size formula. Section 5 applies the proposed methods to the Study of Osteoporotic Fractures (SOF). Section 6 presents simulation experiments, and Section 7 offers discussion and conclusions.
2 Index of Diagnostic Utility Improvement
We use bold letters for vectors and matrices. Let be p-dimensional normally distributed diagnostic variables. A superscript indicates observations from diseased (k=1) or non-diseased (k=0) populations; thus X(0) is independent of X(1) (i.e., X(0) ⊥ X(1)). Let For a p-dimensional vector a, the AUC of the ROC curve constructed by the linear combination a′X is
where , , and Φ is the cumulative distribution function (CDF) of the standard normal distribution. As Su and Liu (Su and Liu, 1993) pointed out, the linear discriminant function
| (1) |
(or ) maximizes the AUC as
| (2) |
Thus the AUC of the OLC is a monotonic function of the quadratic form of a standardized mean shift in a unit of the inverse covariance matrix, . The ROC curve of the OLC is
| (3) |
Adding a combination of q new variables Y = (Y1, Y2, ⋯, Yq)′ to X will increase the AUC of the ROC curve. To determine the significance of the difference in the AUCs for the OLC of X versus OLC of (X′, Y′)′, we first give the following theorem that characterizes the amount of AUC increment by decomposing the quadratic form of the standardize mean shift of L(X,Y) in (2) in comparison to that of L(X).
Theorem 2.1
Let θL(X) and θL(X,Y) be the maximum AUC of the OLCs of X and (X′, Y′)′, denoted as L(X) and L(X, Y), respectively. Suppose (X′(k), Y′(k))′ ~ N (μ(k), Σ(k)) and the OLC residuals of Y on X, . Then
| (4) |
where and .
Therefore the incremental utility of adding Y to X in the AUC can be determined by
| (5) |
in a quadratic form of the residuals , which is a monotone function of difference between squared roots of AUCs and represents the additionally standardized mean shift for OLC due to Y after removing all contributions of X. Note that the regression coefficient is different from the ordinal least squared estimator of the regression coefficient of Y on X.
From (5), we have the following theorem.
Theorem 2.2
Suppose X,(k), , and be the p, q, and r-dimensional normally distributed diagnostic variables (k=0,1 for non-diseased and diseased subjects, respectively), then the incremental utility of (X, Y1, Y2) over X is additive, i.e.,
| (6) |
Proof of Theorems is in Appendix A.
3 Estimation
Under the multivariate normality assumption, the incremental AUC of (X, Y) over X alone is uniquely determined by (5). Suppose that we have independent and identically-distributed (i.i.d) random samples , i = 1,2,…, nk from N (μ(k), Σ(k)), where the subscripts indicate vector components from the ith subject in the kth group. Denoting sample means and covariance matrices for each group k as, X̄(k), Ȳ(k), , , and , is the consistent estimator of regression coefficient β, with , , and
| (7) |
be the residuals. We define the sample mean and covariance , of as
| (8) |
| (9) |
We estimate λ (5) by
| (10) |
Conditioning on β̂, can be regarded as i.i.d samples. Therefore the distribution of statistic λ̂ in (10) is related to a noncentral F- distribution, according to Reiser and Faraggi (Reiser and Faraggi, 1997). However, the common estimator β̂ introduces additional correlations among , and thus . In the Appendix B, we prove
| (11) |
where , with
| (12) |
| (13) |
and
| (14) |
where vec means vector operator, ⊗ is the Kronecker product, Ip2 is a p2 × p2 identity matrix, Kpp is a p2 × p2 commutation matrix. We can estimate V1, V2 by substituting sample means, sample variances, mean squared residual, and β̂(k) for μ’s, Σ’s, var(e) and β(k) in (13) and (14), and denote them by V̂1, V̂2. Let
| (15) |
where , and MSE(k) is the mean squared error of observed residuals. In addition, from the Appendix C, we can derive the distribution of λ̂ as
| (16) |
where
It’s easy to get υ̂ = 1 when only adding one variable Y is added over X.
In the special case when λ=0, i.e, there is no improvement from Y beyond X, (f̂ − p − q + 1)/[(f̂ − p) υ̂]ĉλ̂ follows central F distribution with degrees of freedom υ̂ and f̂ − p − q + 1.
4 Hypothesis Test
Statistical inference of whether adding new variables (diagnostic test 1) is superior to existing variables (test 2) is based on testing a one-sided hypothesis about the difference in their AUCs, i.e., H0 : θ1 − θ2 ≤ Δ versus H1 : θ1 − θ2 > Δ, where Δ ≥ 0 is a prespecified superiority margin and θi’s are the corresponding AUCs. A conventional test statistic is
| (17) |
which asymptotically follows a standard normal distribution. The key of this conventional approach is to derive the unbiased estimates of AUCs θ̂1 and θ̂2 respectively for the best combinations of vectors X and (X′, Y′)′. A naïve approach to use test statistic (17) is to use the nonparametric formula by DeLong, DeLong and Clarke-Pearson (DeLong, DeLong and Clarke-Pearson, 1988) to estimate difference in AUCs and its variance based on the two linear discriminant function scores for combinations of markers. When the diagnostic procedures follow bivariate normal distributions, there is also a parametric approach based on the parameters from normal distributions (Metz, 1986). Both approaches ignore uncertainties introduced in estimating linear discriminant functions, and the overly optimistic estimates of AUCs because of the same data being used for fitting and evaluating models. Although Janes, Longton and Pepe (Janes, Longton and Pepe, 2009) proposed use of cross-validation (CV) to correct for the over optimism, they used naïve estimates from Stata in their examples to compare the ROC curves for the two linear prediction models for all subjects that still utilized same data for fitting and testing.
Alternative to direct comparisons of AUCs, Liu et al (Liu, et al, 2006) proposed inverse normal transformation of AUC and evaluate difference Φ−1 (θ̂1) − Φ−1 (θ̂2) to assess the equivalence or non-inferiority of two diagnostic variables. The difference reflects the standardized mean shift between two ROC models. Liu and colleagues demonstrated improvement in statistical consistency and efficiency by using the standardized difference in comparison to AUCs. Our λ in (5) is a natural generalization from their standardized difference to multivariate linear combinations of L(X) and L(X,Y). The hypotheses to be tested are
| (18) |
where the margin δ can be determined from AUC difference Δ by the relationship of
Using λ̂ defined in (10) and distribution property of (16), we reject the null hypothesis for a too large (f̂ − p − q + 1)/[(f̂ − p) υ̂]ĉλ̂. That is to reject null H0 : λ ≤ δ at significance level α if
| (19) |
where denotes the 100α quintile of the F distribution F(.; df1, df2, ncp) and the p-value is 1 − F ((f̂ − p − q + 1)/((f̂ − p)υ̂)ĉλ̂; υ̂, f̂ − p − q + 1, f̂/(f̂ − p)ĉδ). The statistical power is
| (20) |
It is easy to see that the power depends on the degrees of freedom or sample size, superiority margin δ, and the true amount of improvement λ. Thus, for a given type I error rate α, expected power 1-β, λ under the alternative hypothesis δ, and covariance matrices, we can get the degrees of freedom f̂ and corresponding required sample size.
When superiority margin δ → 0, the superiority test is simplified as the conventional hypothesis test for H0 : λ = 0 versus H1 : λ >0. Test statistics (f̂ − p − q + 1)/[(f̂ − p)υ̂]ĉλ̂ is central F(.; υ̂, f̂ − p − q + 1, 0) distributed under H0 : λ = 0. Therefore combining Y with X presents an improvement beyound X alone when .
5 An Example of Application
Between September 1986 and October 1988, 9,704 ambulatory white women aged 65 years or older without bilateral hip replacements were recruited from population-based listings in four United States cities in the Study of Osteoporotic Fractures (SOF, http://sof.ucsf.edu/Interface/). At the second visit (1988-89), 7,784 women (82% of the survivors at that time) had bone mineral density (BMD) measurements of the posterior-anterior (PA) spine (SBMD) and proximal femoral neck (NBMD), trochanteric (TRBMD), intertrochanteric (INTRBMD), and total hip (TBMD) using dual x-ray absorptiometry (DXA) scanners, and at the calcaneus, distal radius (DBMD), and proximal radius (PBMD) using single photon absorptiometry (SPA) scanners. Besides BMD, additional information, including age, weight, height, and body mass index (BMI), was also collected at all visits. The women were followed for hip fracture by letter or telephone every 4 months for an average of 4.1 years with 99 percent completion. Reported hip fractures were confirmed by a radiologist from preoperative radiographs. Details of the study design and summary statistics of SOF have been published previously (Cummings et al., 1993; Cummings et al., 1995) and available online.
To apply our method to the SOF data, we examined whether TBMD measured by a hip DXA scan or PBMD measured by a SXA forearm scan or their combination can provide incremental diagnostic information for 10-year hip fracture risk beyond BMI and height. The case group consists of women who developed hip fracture during 10 years follow-up. The control group consists of women who had been followed for more than 10 years without hip fracture. To illustrate our method, we select a random subset of 1275 women with a 1:2 age-matched cases and controls. Table 1 summarizes our data samples.
Table 1.
Summary statistics of BMI, height, TBMD and PBMD (Mean ± SD)
| Controls (n0=850) | Fractured Subjects (n1=425) | |
|---|---|---|
|
| ||
| BMI | 26.269 ± 4.232 | 25.431 ± 4.345 |
| Height | 158.612 ± 5.765 | 158.604 ± 6.491 |
| TBMD | 0.755 ± 0.127 | 0.668 ± 0.106 |
| PBMD | 0.629 ± 0.103 | 0.602 ± 0.103 |
To improve the normality fit, we made a natural log transformation of BMI (lnBMI). Quantile-quantile plots for TBMD, PBMD, lnBMI, and height fit normal distributions well. Based on (Su and Liu, 1993), the OLC is the linear discriminant functions (LDF). For X = (lnBMI, Height), LDF is −2.139 × lnBMI −0.0008 × height, with AUC=0.560. For (X,Y) = (lnBMI, height, TBMD), LDF is 1.580×lnBMI+0.016×height −3.600×TBMD, with AUC=0.706. For (X,Y)=(lnBMI, height, PBMD) LDF is −1.519×lnBMI −0.004×height −1.105×PBMD, with AUC=0.584. The ROC curves for the OLCs are shown in Figure 1.
Fig. 1.

ROC curves for OLCs for (1) lnBMI, height (dotted line); (2) lnBMI, height, TBMD (solid line); (3) lnBMI, height, PBMD (dashed line).
Suppose the superiority margin Δ=0.05 for AUC difference, the corresponding margin δ for λ is
Table 2 gives the estimates λ̂, ĉ, f̂ for adding TBMD or PBMD. The degree of freedom from numerator may be different from the number of added diagnostic variables, although it is always 1 from adding only 1 variable. For the given margin δ=0.055, the one-sided p-values are <0.0001 for λ̂ (TBMD∣lnBMI, height), 0.978 for λ̂ (PBMD∣lnBMI, height), and <0.0001 for λ̂ (TBMD,PBMD∣lnBMI, height) based on equation (16). So we reject H0 : λ ≤ δ for adding TBMD but accept H0 for PBMD. Therefore, we conclude that at the 0.05 significance level (1) the addition of TBMD by hip DXA scan significantly increase diagnostic accuracy from using only lnBMI and height; (2) the addition of PBMD by SXA scan doesn’t significantly improve diagnostic accuracy from using only lnBMI and height. Furthermore, by testing λ̂(TBMD∣PBMD,lnBMD,height) directly, we compared λ̂(TBMD,PBMD∣lnBMI,height) =0.2882 versus λ̂(PBMD ∣ lnBMI,height) according to Theorem 2.2 and showed significant benefit of including TBMD on top of lnBMI, height, and PBMD.
Table 2.
The estimations λ̂, ĉ, f̂, and p values for the SOF Example for X=(lnBMI,height)
| TBMD∣X | PBMD∣X | (TBMD,PBMD)∣X | TBMD∣(PBMD, X) | |
|---|---|---|---|---|
|
| ||||
| λ̂ | 0.2710 | 0.0224 | 0.2882 | 0.2658 |
| ĉ | 597.110 | 560.732 | 594.803 | 578.422 |
| υ̂ | 1 | 1 | 2.076 | 1 |
| f̂ | 1035.129 | 1035.096 | 1035.144 | 1035.144 |
| P(Δ=0.05)a | 0.0000 | 0.9780 | 0.0000 | 0.0000 |
| P(Δ=0.10) | 0.0007 | 1.0000 | 0.0002 | 0.0012 |
Superiority margin Δ=0.05 (δ=0.055) or Δ=0.10 (δ=0.147) for superiority test
Using formula (20), we can calculate sample size needed in planning a study. For example, to use a superiority margin δ=0.147, α=0.05, and λ=0.271, we will need 248 cases and 496 controls (in 1:2 ratio) or 347 cases and 347 controls (in 1:1 ratio) to assure 80% statistical power of the study.
6 Simulation Studies
In simulation studies under Gaussian assumption, we specify mean vectors and covariance matrices based on the values in the SOF sample. Let X = (lnBMI, height)′; k = 1 for hip fracture within 10 years and k = 0 otherwise; and (Y1, Y2)′ =(TBMD, PBMD)′. Accordingly, the means and covariance matrices for (lnBMI, height, TBMD, PBMD)′ are μ(0) =(1.179, 158.612, 0.755, 0.629)′, μ(1) =(1.169, 158.604, 0.668, 0.602)′, and
for controls and cases, respectively. In addition, we add a Y3 = lnBMI+ε, where ε is Gaussian noise N(0, 4 Var(l nBMI)). So Y3 is conditional independent with the fracture outcome for given X. Therefore there is no benefit adding Y3 over X. Let Y = (Y1, Y2, Y3)′. Because the equality of population covariance matrices affects the distribution of the estimator, we simulate two scenarios:
Experiment 6.1: Σ(0) = C(0), Σ(1) = C(1) and and
Experiment 6.2: Σ(0) = Σ(1) = (C(0) + C(1))/2 and .
Simulations are run by generating observations from a multivariate normal distribution. For each scenario, we reduplicated 10,000 times. Each replication generates n=n0 + n1 observations of cases (n1) and controls (n0). The proportion of replications rejecting H0 is used to estimate the probability of type I error or power when α=0.05 and superiority margin δ are specified. When we specify δ=0.1λ(Y1∣X1, X2) and n0 : n1 = 1 in Experiment 6.1, to achieve 80% power, n=104 subjects are needed to test the additive utility Y1 over X1, X2, for our proposed method. Thus we choose n=120 as the largest sample size in simulation studies.
Firstly, we evaluate possible estimation bias of effect size for our quadratic index and estimation of AUC difference using non-parametric AUC estimators (DeLong et al., 1988). One of non-parametric estimations is derived from naïve procedure where we fit OLCs and then assess the non-parametric AUCs from the the predicted values for all subjects in the same dataset. Another non-parametric estimation is derived via cross-validation (CV) technique (Janes, Longton and Pepe, 2009), where different datasets are used in OLCs constructing and OLCs predicting. In a K-fold cross-validation, the original subset is partitioned into K subsets with almost equal sample size. Leave out one subset by turn, we construct OLCs from the remaining K − 1 subsets and applied the fitted linear functions OLCs to the leave-out subset and then get the predicted values for the subjects in the leave-out subset. Repeat the process K times, we’ll get the predicted values for all subjects, and then derive the corresponding non-parametric AUC estimations. Tables 3 reports the bias of the estimations of the three approaches for utility of (Y1,Y2) over (X1,X2) when (n0, n1) = (60,60) under Experiment 6.1. Here, for CV procedure, we applied 60-fold CV to the dataset with one case and one control in each subset. The bias is defined as the difference between sample mean estimation versus the theoretical mean value in 10,000 runs. According to F distribution, the bias for λ̂ is calculated by
The bias in AUC difference was asympotically normal and estimated by . The relative bias is defined as bias relative to the corresponding true value.
Table 3.
Bias and standard error (SE) of estimations for utility of (Y1,Y2) over (X1,X2) in Experiment 6.1 when (n0, n1) = (60,60) in 10,000 Runs
| Naive AUC Bias±SE (relative bias) | CV-based AUC Bias±SE (relative bias) | Quadratic-form-based λ Bias±SE (relative bias) | |
|---|---|---|---|
|
| |||
| (X1,X2) (θ=0.5599) | 0.0255±0.000427 (4.55%)* | -0.0312±0.000512 (-5.58%) | |
| (X1,X2,Y1,Y2) (θ=0.7114) | 0.0180±0.000442 (2.53%) | -0.0646±0.000563 (-9.09%) | |
| (Y1,Y2) over (X1,X2) (Δθ=0.1516, λ=0.2882) | -0.0075±0.000515 (-4.93%) | -0.0334±0.000564 (-22.05%) | 0.0007±0.001292 (0.25%) |
Relative bias is bias divided by the true value expressed in percentage.
We find the non-parametric estimations of the AUCs from both naïve procedure and CV procedure to be biased. The naïve procedure over-estimates, whereas 60-fold CV procedure under-estimates the AUCs of the OLCs, i.e. 60-fold CV procedure over corrects the overoptimism from naïve procedure. Both under-estimates the additive performance of (Y1,Y2) over (X1,X2). For example, when n0=n1=60 in Experiment 6.1, the mean AUC difference by naïve estimation from 10,000 runs is 0.1441, whereas the true difference is 0.1516. The agreement in λ is substantially better. Figure 2 shows histograms for the λ-based and naïve non-parametric θ-based test statistics for direct comparison of AUC difference (17) (DeLong et al., 1988) from 10,000 runs to test the additive utility of (Y1,Y2) over (X1,X2) when n0=n1=60 in Experiment 6.1. Even after bias correction, the empirical type I error rate is still about half of 0.05. Our simulations show the naïve non-parametric statistic is positive skewed from a standard normal distribution when sample size is not big enough. Because of the bias or departure from null distribution, the AUC-based method from naïve procedure or CV procedure will not maintain proper the I error rate, and will not get correct power either. So next, we only present empirical type I error rate and power for the newly proposed method.
Fig. 2.


Histograms of λ-based test statistic and naïve non-parametric θ-based test statistic from 10,000 runs to test additive utility of (Y1,Y2) over (X1,X2) when n0=n1=60 in Experiment 6.1.
(1) Histograms of quadratic-form-based test statistic.
Noncentral distribution under null hypothesis (solid curve); 95% quantile of the null distribution(dashed line).
(2) Histograms of classic non-parametric AUC-based test statistic.
Standard normal distribution under null hypothesis (solid curve); 5% and 95% quantiles of standard normal distribution (dashed line); Bias corrected normal distribution under null hypothesis (dotted curve); 5% and 95% quantiles of bias corrected normal distribution (dotted line).*
Tables 4 and 5 report the empirical type I error rate and power to test the incremental utilities of adding Y1, Y2, Y3, (Y1, Y2)′, (Y1, Y2, Y3)′, (Y1, Y2, Y3)′ and (Y1, Y2, Y3)′ over X = (X1, X2)′ under Gaussian assumption with experimental conditions 6.1 and 6.2 with sample sizes (n0, n1) = (30,30), (40,20), (60,60), and (80,40). They demonstrate accurate type I error rates as well as practically acceptable statistical power of the newly proposed method for assessing the added diagnostic utility. The simulations show when the variable Y3 with no benefit over X is added to Y1 or Y2, the power decreased as expected.
Table 4.
Empirical type I error rates and power for Experiment 6.1 under Gaussian distribution (10,000 Runs)
| Margin δ | Y3∣X λ=0 | Y1∣X λ=0.271 | (Y1, Y3)∣X λ=0.271 | Y2 ∣X λ=0.022 | (Y2,Y3)∣X λ=0.022 | (Y1,Y2)∣X λ=0.288 | (Y1,Y2,Y3)∣X λ=0.288 |
|---|---|---|---|---|---|---|---|
| (n0,n1)=(30,30) | |||||||
| δ=λ | 0.0448 | 0.0436 | 0.0460 | 0.0430 | 0.0453 | 0.0437 | 0.0458 |
| δ=0.5λ | --- | 0.1769 | 0.1726 | 0.0683 | 0.0621 | 0.1753 | 0.1684 |
| δ=0.1λ | --- | 0.5638 | 0.5153 | 0.1023 | 0.0845 | 0.5222 | 0.4873 |
| (n0,n1)=(40,20) | |||||||
| δ=λ | 0.0481 | 0.0430 | 0.0433 | 0.0439 | 0.0445 | 0.0443 | 0.0415 |
| δ=0.5λ | --- | 0.1734 | 0.1538 | 0.0662 | 0.0595 | 0.1647 | 0.1495 |
| δ=0.1λ | --- | 0.5362 | 0.4579 | 0.0958 | 0.0769 | 0.4817 | 0.4245 |
| (n0,n1)=(60,60) | |||||||
| δ=λ | 0.0473 | 0.0493 | 0.0472 | 0.0483 | 0.0492 | 0.0493 | 0.0475 |
| δ=0.5λ | --- | 0.2897 | 0.2846 | 0.0918 | 0.0853 | 0.2966 | 0.2882 |
| δ=0.1λ | --- | 0.8446 | 0.8145 | 0.1695 | 0.1296 | 0.8307 | 0.8069 |
| (n0,n1)=(80,40) | |||||||
| δ=λ | 0.0497 | 0.0442 | 0.0472 | 0.0479 | 0.0510 | 0.0458 | 0.0460 |
| δ=0.5λ | --- | 0.2765 | 0.2701 | 0.0836 | 0.0834 | 0.2751 | 0.2710 |
| δ=0.1λ | --- | 0.8182 | 0.7798 | 0.1533 | 0.1241 | 0.8034 | 0.7665 |
Table 5.
Empirical type I error rates and power for Experiment 6.2 under Gaussian distribution (10,000 Runs)
| Margin δ | Y3∣X λ=0 | Y1∣X λ=0.271 | (Y1,Y3)∣X λ=0.271 | Y2 ∣X λ=0.022 | (Y2,Y3)∣X λ=0.022 | (Y1,Y2)∣X λ=0.288 | (Y1,Y2,Y3)∣X λ=0.288 |
|---|---|---|---|---|---|---|---|
| (n0,n1)=(30,30) | |||||||
| δ=λ | 0.0461 | 0.0460 | 0.0456 | 0.0445 | 0.0463 | 0.0457 | 0.0447 |
| δ=0.5λ | --- | 0.1817 | 0.1719 | 0.0701 | 0.0625 | 0.1763 | 0.1694 |
| δ=0.1λ | --- | 0.5732 | 0.5044 | 0.1091 | 0.0826 | 0.5291 | 0.4780 |
| (n0,n1)=(40,20) | |||||||
| δ=λ | 0.0444 | 0.0485 | 0.0434 | 0.0470 | 0.0431 | 0.0461 | 0.0456 |
| δ=0.5λ | --- | 0.1704 | 0.1584 | 0.0702 | 0.0615 | 0.1656 | 0.1535 |
| δ=0.1λ | --- | 0.5110 | 0.4591 | 0.0999 | 0.0777 | 0.4709 | 0.4277 |
| (n0,n1)=(60,60) | |||||||
| δ=λ | 0.0474 | 0.0479 | 0.0425 | 0.0511 | 0.0469 | 0.0466 | 0.0445 |
| δ=0.5λ | --- | 0.2893 | 0.2772 | 0.0935 | 0.0806 | 0.2966 | 0.2780 |
| δ=0.1λ | --- | 0.8367 | 0.8113 | 0.1746 | 0.1312 | 0.8299 | 0.8100 |
| (n0,n1)=(80,40) | |||||||
| δ=λ | 0.0497 | 0.0444 | 0.0493 | 0.0488 | 0.0488 | 0.0454 | 0.0489 |
| δ=0.5λ | --- | 0.2643 | 0.2642 | 0.0856 | 0.0779 | 0.2626 | 0.2650 |
| δ=0.1λ | --- | 0.7997 | 0.7555 | 0.1561 | 0.1267 | 0.7845 | 0.7459 |
7 Discussion
The AUC under an ROC curve measures diagnostic accuracy for discriminating diseased from nondiseased subjects. In a binormal ROC model, the difference in AUC can be more accurately and efficiently compared via the mean shift relative to the variance (Liu et al., 2006). The incremental diagnostic accuracy by adding new variables has to be evaluated based on the increase in the AUC of ROC curves (Pepe et al., 2004; Wang et al., 2006; Ware, 2006). Parametric approaches used the binormal distribution models (Metz, 1986) or non-parametric estimation by DeLong et al (DeLong et al., 1988) can evaluate differences in AUCs from randomized clinical trials if one group diagnosed with X only and another group uses the combination of X and Y. However, in a paired design commonly used in diagnostic trials, we need to use the data first to fit OLCs based on the linear discriminant functions of X and the combination of X and Y. Theorem 2.1 proves that the gain in AUCs is a function of regression residuals of Y on X, and the regression coefficient estimator β̂ introduces non-linear correlated in AUC differences based on OLCs. If we use the predicted OLC values directly in evaluation of AUC difference, we will result in biased estimation of AUC gain and variance in practical sample sizes. The resulting statistical tests will be biased. Fitting and evaluating models on the same data is known to produce overly optimistic estimates of model performance. CV procedure will correct the overoptimism but also have a risk of underestimation the true difference under practical sample sizes. Our simulations show 60-fold CV procedure over corrects the overoptimism for the specific simulation data. Our proposed index is a function of transformed AUC differences and has desired statistical consistency and efficiency demonstrated in our simulation studies. Pencina et al. (Pencina et al., 2008) introduced two alternative measures to assess the clinical benefits of adding new diagnostic variables, one based on integrated sensitivity and specificity, and the other on event-specific reclassification tables. Further research is needed to evaluate these metrics.
We formulated the incremental diagnostic utility of adding new variables Y = (Y1, Y2, ⋯, Yq)′ to the existing diagnostic variables X = (X1, X2, ⋯, Xp)′ under a multivariate normal distributional assumption by quadratic form with , where λ reflects a quadratic form of mean shift relative to the variance from Z. We account the uncertainties introduced in estimating linear discriminant functions into the distribution of Z. The inference based on λ̂ estimates fewer parameters than non-parametric approaches to compare AUCs of L(X), L(X,Y), which require estimates of variance and covariance of the AUCs. In addition, it has no ceiling (≤1) nor floor (≥0.5) effect in this index. As with the one-dimensional case (Liu et al., 2006), the λ-based method maintains the correct type I error rate and is more efficient than AUC-based methods.
The distribution estimator λ̂ is related to the multivariate Behrens–Fisher problem. In deriving the distribution, we did not limit ourselves to special conditions, such as . For special conditions of homogenous covariance matrixes , there are more efficient estimators, such as the conventional Hotelling T2 test. Our simulations cover both conditions of with and without homogeneous covariance, and the results show that the test statistics (19) maintain the proper type I error rate under both conditions. It can also be used to evaluate sample size needed for such studies.
One major limitation of current approach is the assumption of multivariate normal distributions of diagnostic variables. Because the most important derivations relate to the residual Z, it should be possible to relax the multivariate normal assumptions by requiring multivariate normal distribution assumption only to the residual Z. Further studies are necessary to confirm this conjecture. If we fail to make proper variable transformation to fit a multivariate normal distribution, we can always use the bootstrap method to derive the empirical p-value. The bootstrap method, however, will not help the sample size calculation when we plan a study.
In summary, we derived a new test statistic to efficiently determine the statistical significance of an incremental AUC under a multivariate normal assumption. Our test links the difference in AUC to a quadratic form of standardized mean shift relative to the covariance after a properly linear transformation of all diagnostic variables. The distribution of the estimator of the quadratic form is related to the multivariate Behrens-Fisher problem. We provide an explicit mathematical solution of the estimator and its approximate noncentral F-distribution, type I error rate, and sample size formula. Our simulation studies demonstrate that our new test maintains the prespecified type I error rates as well as satisfactory statistical power under practical sample sizes. In addition, our simulation study suggests that the proposed estimator and test statistics maintain the correct type I. We use an example of predicting osteoporotic hip fracture to illustrate our method.
Acknowledgments
This work is supported by National Institutes of Health R01EB 004079 to the University of California, San Francisco (P.I. Lu). The authors thank Mr. Phil Chu and Dr. John Kornak for their helpful comments. They also thank for the associate editor and anonymous reviewer for their constructive suggestions that significantly improved the paper.
Appendix A
Proof of Theorem 2.1
We give two lemmas first.
Lemma 1
If X̃ is a nonsingular linear transformation of X, the maximum AUC for the linear combination of X̃ is the same as that of X, i.e. θL(X̃) = θL(X).
The lemma is obvious because X̃ and X are linear combinations of each other. Let , and μ = μ(1) − μ(0), Σ = Σ(1) + Σ(0).
Lemma 2
If (X′(k), Y′(k))′ : N(μ(k), Σ(k)), with and , then
with , and . Hence
Because (X′, Z′)′ is a linear transformation of (X′, Y′)′, according to the above Lemmas 1 and 2, we proved Theorem 2.1.
Appendix B
Moments of
Because
with
β̂ is an asymptotic unbiased estimator of β since S is an unbiased estimator of Σ, and S−1 is an asymptotic unbiased estimator of Σ−1. So is a consistent estimator of .
Note that is the regression coefficient for , where , and the error term e(k) follows a q-dimensional normal distribution with mean vector 0 and e(k) ⊥ X(k).
| (A.1) |
where, vec means vector operator, and
| (A.2) |
| (A.3) |
can be derived from the delta method. Note that
Adopting the first-order Taylor approximation,
where Kpp is denoted the p2 × p2 commutation matrix, defined as
where Hij denote the p × p matrix with the element hij =1 and all other elements equal to 0. Note that β̂ ⊥ (Ȳ(1), Ȳ(0), X̄(1), X̄(0)), hence
Here, we only omit a term O(min(n0,n1)−2) in the above approximation. Plugging in Var[vec(β̂′)] from (A.1)-(A.3), we get
| (A.4) |
where
Appendix C
Distribution of Estimator λ̂
Since
Let
where
The distribution of S is related to the multivariate Behrens-Fisher problem.
Following (Nel and Merwe, 1986), approximately,
where
where “tr” means trace. According to the theorem from Muirhead p. 93-97 (Muirhead, 1982),
So E(SZZ) = (f − p) ΣZZ / f. The variance of tends to 0 as n(k) approaches infinity. So SZZ converges in the probability to the value of (f − p)ΣZZ / f. On the basis of the convergence theorem, the asymptotic distribution of λ̂ is the same as the quadratic statistics f / (f − p)Λ1 for large sample size, where
Many exact and approximate methods are available to calculate the distribution of quadratic forms in normal variables, including Patnaik’s two-moment central χ2-approximation (Box, 1954; Patnaik, 1949), Pearson’s three-moment central χ2 approximation etc. (Imhof, 1961; Pearson, 1959). All these estimations were derived either based on an assumption of equal means for Z(1) and Z(0) (thus zero differences) or simply approximate noncentral χ2 by a central χ2 approximation. They are inappropriate to our problem because we want to test the quadratic statistics above a positive non-zero constant. Instead, we use a two-moment noncentral χ2 approximation to calculate the distribution of Λ1. We approximate
with degrees of freedom υ and a noncentral parameter c* λ, where c*, υ are derived from the two-moment equations
and
where , Therefore we get
and
In the special case of ΣZZ = lΣ̃ZZ for a positive constant l, which is always true for one-dimensional q = 1, c* = l, υ = q, lΛ1 = χ2(q, l λ).
So, when n0, n1 are large enough, f / (f − p)Λ1 can directly estimate λ with approximate distribution
For small sample size, however, we cannot simply replace ΣZZ by f(f − p)SZZ. Let
Then λ̂ = Λ1/Λ2 is a Hotelling-T2 type statistic. Although and SZZ may correlate, the correlation between is small as O(min(n0,n1)−1) and we can ignore it. According to the theorem from (Muirhead, 1982), f Λ2 follows a central χ2-distribution with degrees of freedom f − p − q +1. Therefore
| (A.5) |
with degrees of freedom υ, f − p − q + 1 and noncentrality parameter c* λ.
We can estimate f, c*, and υ by substituting S(k), f(f − p)SZZ, and for Σ(k), ΣZZ and ΣZZ,
with
Then (A.5) can be written as
| (A.6) |
Footnotes
Conflict of Interests Statement
The authors have declared no conflict of interest.
References
- Box GEP. Some theorems on quadratic forms applied in the study of analysis of variance problems, I. effect of inequality of variance in the one-way classification. Annals of Mathematical Statistics. 1954;25:290–302. [Google Scholar]
- Cai T, Cheng S. Robust combination of multiple diagnostic tests for classifying censored event times. Biostatistics. 2008;9:216–233. doi: 10.1093/biostatistics/kxm037. [DOI] [PubMed] [Google Scholar]
- Cummings SR, Black DM, Nevitt MC, et al. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet. 1993;341:72–75. doi: 10.1016/0140-6736(93)92555-8. [DOI] [PubMed] [Google Scholar]
- Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995;332:767–773. doi: 10.1056/NEJM199503233321202. [DOI] [PubMed] [Google Scholar]
- DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–845. [PubMed] [Google Scholar]
- Imhof JP. Computing the distribution of quadratic forms in normal variables. Biometrika. 1961;48:419–426. [Google Scholar]
- Janes H, Longton GM, Pepe MS. Accommodating Covariates in ROC Analysis. The Stata Journal. 2009;9:17–39. [PMC free article] [PubMed] [Google Scholar]
- Jin H, Lu Y. A procedure for determining whether a simple combination of diagnostic tests may be noninferior to the theoretical optimum combination. Med Decis Making. 2008;28:909–916. doi: 10.1177/0272989X08318462. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jin H, Lu Y. Permutation test for non-inferiority of the linear to the optimal combination of multiple tests. Statistics & Probability Letters. 2009a;79:664–669. doi: 10.1016/j.spl.2008.10.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jin H, Lu Y. The optimal linear combination of multiple predictors under the generalized linear models. Statistics and Probability Letters. 2009b;79:2321–2327. doi: 10.1016/j.spl.2009.08.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu A, Schisterman EF, Zhu Y. On linear combinations of biomarkers to improve diagnostic accuracy. Stat Med. 2005;24:37–47. doi: 10.1002/sim.1922. [DOI] [PubMed] [Google Scholar]
- Liu JP, Ma MC, Wu CY, Tai JY. Tests of equivalence and non-inferiority for diagnostic accuracy based on the paired areas under ROC curves. Stat Med. 2006;25:1219–1238. doi: 10.1002/sim.2358. [DOI] [PubMed] [Google Scholar]
- McIntosh MW, Pepe MS. Combining several screening tests: optimality of the risk score. Biometrics. 2002;58:657–664. doi: 10.1111/j.0006-341x.2002.00657.x. [DOI] [PubMed] [Google Scholar]
- Metz CE. ROC methodology in radiologic imaging. Investigative Radiology. 1986;21:720–733. doi: 10.1097/00004424-198609000-00009. [DOI] [PubMed] [Google Scholar]
- Muirhead RJ. Aspects of Multivariate Statistical Theory. NewYork: John Wiley & Sons, Inc; 1982. Aspects of Multivariate Statistical Theory; pp. 93–97. [Google Scholar]
- Nel DG, Merwe Vd. A solution to the multivariate Behrens-Fisher problem. Communications in Statistics-- Theory Methods. 1986;15:3719–3735. [Google Scholar]
- Neyman J, Pearson ES. On the problem of the most efficient tests of statistical hypotheses. Philosophical Transactions of the Royal Society of London Series A. 1933;24:289–337. [Google Scholar]
- Patnaik PB. The non-central chi2- and F-distributions and their applications. Biometrika. 1949;36:202–232. [PubMed] [Google Scholar]
- Pearson ES. Note on an approximation to the distribution of non-central χ2. Biometrika. 1959;46:364. [Google Scholar]
- Pencina MJ, D’Agostino RB, Sr, D’Agostino RB, Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157–172. doi: 10.1002/sim.2929. discussion 207-112. [DOI] [PubMed] [Google Scholar]
- Pepe MS, Cai T, Longton G. Combining predictors for classification using the area under the receiver operating characteristic curve. Biometrics. 2006;62:221–229. doi: 10.1111/j.1541-0420.2005.00420.x. [DOI] [PubMed] [Google Scholar]
- Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol. 2004;159:882–890. doi: 10.1093/aje/kwh101. [DOI] [PubMed] [Google Scholar]
- Pepe MS, Thompson ML. Combining diagnostic test results to increase accuracy. Biostatistics. 2000;1:123–140. doi: 10.1093/biostatistics/1.2.123. [DOI] [PubMed] [Google Scholar]
- Reiser B, Faraggi D. Confidence intervals for the generalized ROC criterion. Biometrics. 1997;53:644–652. [PubMed] [Google Scholar]
- Schisterman EF, Faraggi D, Reiser B. Adjusting the generalized ROC curve for covariates. Stat Med. 2004;23:3319–3331. doi: 10.1002/sim.1908. [DOI] [PubMed] [Google Scholar]
- Su JQ, Liu JS. Linear combinations of multiple diagnostic markers. Journal of the American Statistical association. 1993;88:1350–1355. [Google Scholar]
- Wang TJ, Gona P, Larson MG, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006;355:2631–2639. doi: 10.1056/NEJMoa055373. [DOI] [PubMed] [Google Scholar]
- Ware JH. The limitations of risk factors as prognostic tools. N Engl J Med. 2006;355:2615–2617. doi: 10.1056/NEJMp068249. [DOI] [PubMed] [Google Scholar]
